Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been given an average rating of “Buy” by the seven analysts that are presently covering the firm, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the […]